IP Library › Assignment 068083/0212
Patent Assignment
Reel/Frame 068083/0212

Assignment of Assignor's Interest

Recorded: 2024-07-25 Pages: 8
Assignor
Assignee
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA, 540-8645, JAPAN
Covered Properties (2)
Formulation for Anti-ALPHA4BETA7 Antibody
Application: 18/046,450 →
Publication: US 2023/0312727
Treatment with Anti-ALPHA4BETA7 Antibody
Application: 17/239,512 →
Publication: US 2021/0340261
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 25, 2024
From: TAKEDA PHARMACEUTICAL COMPANY LIMITED
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 068083/0220 →
Assignment of Assignor's Interest Jul 25, 2024
From: DILUZIO, WILLOW; NGUYEN, PHOUNG M.; VARGA, CSANAD M.; PALANIAPPAN, VAITHIANATHAN
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 068083/0099 →
Assignment of Assignor's Interest Jul 25, 2024
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 068083/0323 →
Assignment of Assignor's Interest Jul 25, 2024
From: JENKINS, HELEN
To: TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTRE (EUROPE) LTD.
Reel/Frame 068083/0156 →